Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

NCT04539301 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04539301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2021
Completion date
May 1, 2024
Enrollment
2,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulation, atrial fibrillation, venous thromboembolism